Form 4: Tourmaline Bio CEO Acquires Shares in Open Market Purchase

CEO Sandeep Chidambar Kulkarni of Tourmaline Bio, Inc. recently purchased 1,779 shares of common stock at an average price of $14.85.

Summary

• On August 21, 2024, Sandeep Chidambar Kulkarni, the CEO of Tourmaline Bio, Inc., acquired 1,779 shares of the company's common stock.
• The purchase was made at a weighted average price of $14.85 per share, with individual transactions ranging from $14.82 to $14.88.
• Following the transaction, Mr. Kulkarni indirectly owns 7,000 shares through Gilead Capital, LP, where his spouse is a partner with shared voting and investment power.
• Mr. Kulkarni disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CEO's purchase suggests confidence, but it's a relatively small transaction.

Positives

• The CEO's purchase of shares may signal confidence in the company's future prospects.

Industry Context

Insider buying is often seen as a positive sign, suggesting that company leadership believes the stock is undervalued. However, it's just one factor to consider when evaluating a company's potential.

Stakeholder Impact

• The CEO's share purchase could have a slightly positive impact on shareholder sentiment.

Key Dates